Proteomic analysis of Intercept-treated platelets

Journal of Proteomics

Volumn 76, Issue , 2012, Pages 316-328

  Prudent, Michel ^a   Crettaz, David ^a   Delobel, Julien ^a   Tissot, Jean Daniel ^a   Lion, Niels ^a  

^a Service Regional Vaudois de Transfusion Sanguine   (Switzerland)

Author keywords

Amotosalen; Intercept; Pathogen inactivation; Pathogen reduction; Platelets; Transfusion

Indexed keywords

ACTIN; CHLORIDE INTRACELLULAR CHANNEL PROTEIN 4; COFILIN 1; DJ 1 PROTEIN; GLUTAREDOXIN; GLUTAREDOXIN 5; NONOXINOL 9; PROTEIN; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HEMOSTASIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEOMICS; THROMBOCYTE PRESERVATION;

BLOOD BUFFY COAT; BLOOD PLATELETS; BLOOD PROTEINS; FEMALE; HUMANS; MALE; MICROBIAL VIABILITY; PHOTOSENSITIZING AGENTS; PROTEOME; PROTEOMICS; PSORALENS; STERILIZATION;

BACTERIA (MICROORGANISMS);

EID: 84869890236     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.07.008     Document Type: Article

References (92)

1. Niederhauser C., Weingand T., Candotti D., Maier A., Tinguely C., Wuillemin W.A., et al. Fatal outcome of a hepatitis B virus transfusion-transmitted infection. Vox Sang 2010, 98:504-507.
2. Stolz M., Tinguely C., Graziani M., Fontana S., Gowland P., Buser A., et al. Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region. Transfusion 2010, 50:2695-2706.
3. Rüesch M., Jützi M. Annual hemovigilance report 2010 2010, Swissmedic.
4. Lelli R. West Nile virus in Europe: understanding the present to gauge the future. Euro Surveill 2010, 15:19538.
5. Angelini R., Finarelli A.C., Angelini P., Po C., Petropoulacos K., Macini P., et al. An outbreak of chikungunya fever in the province of Ravenna, Italy. Eurosurveillance 2007, 12:3260.
6. Reiter P. Yellow fever and dengue: a threat to Europe?. Euro Surveill. 2010, 15(10):19509. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19509.
7. La Ruche G., Souarès Y., Armengaud A., Peloux-Petiot F., Delaunay P., Desprès P., et al. First two autochthonous dengue virus infections in metropolitan France, September 2010. Euro Surveill 2010, 15:19676.
8. Schaffner F., Faufmann C., Mathis A. The invasive mosquito Aedes japonicus in Central Europe. Med Vet Entomol 2009, 23:448-451.
9. Dodd R., Roth W.K., Ashford P., Dax E.M., Vyas G. Transfusion medicine and safety. Biologicals 2009, 37:62-70.
10. Jenkins C., Ramírez-Arcos S., Goldman M., Devine D.V. Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk. Transfusion 2011, 51:2555-2565.
11. Védy D., Robert D., Canellini G., Waldvogel S., Tissot J.-D. Bacterial contamination of platelet concentrates: pathogen detection and inactivation methods. Hematol Rep 2009, 1.
12. Canellini G., Waldvogel S., Anderegg K., Tissot J.D. Bacterial contamination of platelet concentrates: perspectives for the future. Lab Med 2010, 41:301-305.
13. McDonald C.P. Bacterial risk reduction by improved donor arm disinfection, diversion and bacterial screening. Transfus Med 2006, 16:381-396.
14. Goldman M. Bacterial contamination of platelet concentrates: where are we today?. Vox Sang 2004, 87(Suppl. 2):90-92.
15. Mathai J. Problem of bacterial contamination in platelet concentrates. Transfus Apher Sci 2009, 41:139-144.
16. Blajchman M. Improving the bacteriological safety of platelet transfusions. Transfus Med Rev 2004, 18:11-24.
17. Lai C., Cao H., Hearst J.E., Corash L., Luo H., Wang Y. Quantitative analysis of DNA interstrand cross-links and monoadducts formed in human cells induced by psoralens and UVA irradiation. Anal Chem 2008, 80:8790-8798.
18. Cao H., Hearst J.E., Corash L., Wang Y. LC-MS/MS for the detection of DNA interstrand cross-links formed by 8-methoxypsoralen and UVA irradiation in human cells. Anal Chem 2008, 80:2932-2938.
19. Mccullough J. Pathogen inactivation: a new paradigm for preventing transfusion-transmitted infections. Am J Clin Pathol 2007, 128:945-955.
20. Goodrich R.P., Doane S., Reddy H.L. Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products. Biologicals 2010, 38:20-30.
21. Mohr H., Steil L., Gravemann U., Thiele T., Hammer E., Greinacher A., et al. A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light. Transfusion 2009, 49:2612-2624.
22. Ciaravi V., McCullough T., Dayan A.D. Pharmacokinetic and toxicology assessment of INTERCEPT (S-59 and UVA treated) platelets. Hum Exp Toxicol 2001, 20:533-550.
23. Lin L., Conlan M.G., Tessman J., Cimino G., Porter S. Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment. Transfusion 2005, 45:1610-1620.
24. Lozano M., Galan A., Mazzara R., Corash L., Escolar G. Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7days: assessment of hemostatic function under flow conditions. Transfusion 2007, 47:666-671.
25. Osselaer J.C., Messe N., Hervig T., Bueno J., Castro E., Espinosa A., et al. A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment. Transfusion 2008, 48:1061-1071.
26. Osselaer J.C., Doyen C., Defoin L., Debry C., Goffaux M., Messe N., et al. Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use. Transfusion 2009, 49:1412-1422.
27. Cazenave J.-P., Isola H., Waller C., Mendel I., Kientz D., Laforet M., et al. Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period. Transfusion 2011, 51:622-629.
28. Cazenave J.P. Inactivation des pathogènes des concentrés plaquettaires : expérience française. Transfus Clin Biol 2011, 18:478-484.
29. Kerkhoffs J.-L.H., Van Putten W.L.J., Novotny V.M.J., Boekhorst Te P.A.W., Schipperus M.R., Zwaginga J.J., et al. on behalf of the Dutch-Belgian HOVON cooperative group. Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction. Br J Haematol 2010, 150:209-217.
30. Corash L., Sherman C.D. Evaluation of platelet transfusion clinical trials. Br J Haematol 2011, 153:529-531.
31. Kerkhoffs J.-L.H. Evaluation of platelet transfusion clinical trials-response to Corash & Sherman. Br J Haematol 2011, 153:531-532.
32. Vamvakas E.C. Meta-analysis of the studies of bleeding complications of platelets pathogen-reduced with the Intercept system. Vox Sang 2011, 102:302-316.
33. Vamvakas E.C. Meta-analysis of the randomized controlled trials of the hemostatic efficacy and capacity of pathogen-reduced platelets. Transfusion 2010, 51:1058-1071.
34. Corash L. The hemostatic efficacy of platelet components prepared with pathogen inactivation. Transfusion 2011, 51:1355-1356. authorreply1356-7.
35. Oakley B.R., Kirsch D.R., Morris N.R. A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem 1980, 105:361-363.
36. Rabilloud T. A comparison between low background silver diammine and silver nitrate protein stains. Electrophoresis 1992, 13:429-439.
37. Crettaz D., Sensebe L., Vu D.-H., Schneider P., Depasse F., Bienvenut W.-V., et al. Proteomics of methylene blue photo-treated plasma before and after removal of the dye by an absorbent filter. Proteomics 2004, 4:881-891.
38. Candiano G., Bruschi M., Musante L., Santucci L., Ghiggeri G.M., Carnemolla B., et al. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 2004, 25:1327-1333.
39. Wilm M., Shevchenko A., Houthaeve T., Breit S., Schweigerer L., Fotsis T., et al. Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature 1996, 379:466-469.
40. Shevchenko A., Zachariae W., Shevchenko A. A strategy for the characterization of protein interaction networks by mass spectrometry. Biochem Soc Trans 1999, 27:549-554.
41. Moebius J., Zahedi R.P., Lewandrowski U., Berger C., Walter U., Sickmann A. The human platelet membrane proteome reveals several new potential membrane proteins. Mol Cell Proteomics 2005, 4:1754-1761.
42. Dittrich M., Birschmann I., Mietner S., Sickmann A., Walter U., Dandekar T. Platelet protein interactions: map, signaling components, and phosphorylation groundstate. Arterioscler Thromb Vasc Biol 2008, 28:1326-1331.
43. Kahle P.J., Waak J., Gasser T. DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders. Free Radic Biol Med 2009, 47:1354-1361.
44. Saeed U., Ray A., Valli R.K., Kumar A.M.R., Ravindranath V. DJ-1 loss by glutaredoxin but not glutathione depletion triggers Daxx translocation and cell death. Antioxid Redox Signal 2010, 13:127-144.
45. Duan X., Kelsen S.G., Merali S. Proteomic analysis of oxidative stress-responsive proteins in human pneumocytes: insight into the regulation of DJ-1 expression. J Proteome Res 2008, 7:4955-4961.
46. Zhou W., Zhu M., Wilson M.A., Petsko G.A., Fink A.L. The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein. J Mol Biol 2006, 356:1036-1048.
47. Johansson C., Roos A.K., Montano S.J., Sengupta R., Filippakopoulos P., Guo K., et al. The crystal structure of human GLRX5: iron-sulfur cluster co-ordination, tetrameric assembly and monomer activity. Biochem J 2010, 433:303-311.
48. Schubert P., Culibrk B., Coupland D., Scammell K., Gyongyossy-Issa M., Devine D.V. Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage. Transfusion 2012, 52:397-408.
49. Thiele T., Sablewski A., Iuga C., Bakchoul T., Bente A., Görg S., Völker U., Greinacher A., Steil L. Profiling alterations in platelets induced by Amotosalen/UVA pathogen reduction and gamma irradiation-a LC-ESI-MS/MS-based proteomics approach. Blood Transfus 2012, 10(Suppl 2):s63-s70.
50. Prudent M., Tissot J.-D., Lion N. Proteomics of blood and derived products: what's next?. Expert Rev Proteomics 2011, 8:717-737.
51. Lion N., Prudent M., Crettaz D., Tissot J.D. Proteomics and transfusion medicine. Transfus Clin Biol 2011, 18:79-96.
52. Delobel J., Rubin O., Prudent M., Crettaz D., Tissot J.-D., Lion N. Biomarker analysis of stored blood products: emphasis on pre-analytical issues. Int J Mol Sci 2010, 11:4601-4617.
53. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nature 2003, 422:198-207.
54. Rabilloud T., Chevallet M., Luche S., Lelong C. Two-dimensional gel electrophoresis in proteomics: past, present and future. J Proteomics 2010, 73:2064-2077.
55. Thon J.N., Schubert P., Devine D.V. Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches. Transfusion 2008, 48:425-435.
56. Thiele T., Steil L., Gebhard S., Scharf C., Hammer E., Brigulla M., et al. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 2007, 47:1221-1233.
57. Honbou K., Suzuki N.N., Horiuchi M., Taira T., Niki T., Ariga H., et al. Crystallization and preliminary crystallographic analysis of DJ-1, a protein associated with male fertility and parkinsonism. Acta Crystallogr D Biol Crystallogr 2003, 59:1502-1503.
58. Huai Q., Sun Y., Wang H., Chin L.S., Li L., Robinson H., et al. Crystal structure of DJ-1/RS and implication on familial Parkinson's disease. FEBS Lett 2003, 549:171-175.
59. Honbou K., Suzuki N.N., Horiuchi M., Niki T., Taira T., Ariga H., et al. The crystal structure of DJ-1, a protein related to male fertility and Parkinson's disease. J Biol Chem 2003, 278:31380-31384.
60. Canet-Avilés R.M., Wilson M.A., Miller D.W., Ahmad R., McLendon C., Bandyopadhyay S., et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci USA 2004, 101:9103-9108.
61. Xiong H., Wang D., Chen L., Choo Y.S., Ma H., Tang C., et al. Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J Clin Invest 2009, 119:650-660.
62. Gu L., Cui T., Fan C., Zhao H., Zhao C., Lu L., et al. Involvement of ERK1/2 signaling pathway in DJ-1-induced neuroprotection against oxidative stress. Biochem Biophys Res Commun 2009, 383:469-474.
63. Kamp F., Exner N., Lutz A.K., Wender N., Hegermann J., Brunner B., et al. Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J 2010, 29:3571-3589.
64. Zhou W., Bercury K., Cummiskey J., Luong N., Lebin J., Freed C.R. Phenylbutyrate up-regulates the DJ-1 protein and protects neurons in cell culture and in animal models of Parkinson disease. J Biol Chem 2011, 286:14941-14951.
65. Xu X.M., Lin H., Maple J., Bjorkblom B., Alves G., Larsen J.P., et al. The Arabidopsis DJ-1a protein confers stress protection through cytosolic SOD activation. J Cell Sci 2010, 123:1644-1651.
66. Wingert R.A., Galloway J.L., Barut B., Foott H., Fraenkel P., Axe J.L., et al. Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature 2005, 436:1035-1039.
67. Camaschella C., Campanella A., De Falco L., Boschetto L., Merlini R., Silvestri L., et al. The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload. Blood 2007, 110:1353-1358.
68. Shenton D., Perrone G., Quinn K.A., Dawes I.W., Grant C.M. Regulation of protein S-thiolation by glutaredoxin 5 in the yeast Saccharomyces cerevisiae. J Biol Chem 2002, 277:16853-16859.
69. Herrero E., Torre-Ruiz M.A. Monothiol glutaredoxins: a common domain for multiple functions. Cell Mol Life Sci 2007, 64:1518-1530.
70. Burch P.T., Burch J.W. Alterations in glutathione during storage of human platelet concentrates. Transfusion 1987, 27:342-346.
71. Larson M.K. Identification of P2Y12-dependent and -independent mechanisms of glycoprotein VI-mediated Rap1 activation in platelets. Blood 2002, 101:1409-1415.
72. Jin J., Kunapuli S.P. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci U S A 1998, 95:8070-8074.
73. Woulfe D., Yang J., Brass L. ADP and platelets: the end of the beginning. J Clin Invest 2001, 107:1503-1505.
74. Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res 2006, 99:1293-1304.
75. Garcia A., Kim S., Bhavaraju K., Schoenwaelder S.M., Kunapuli S.P. Role of phosphoinositide 3-kinase β in platelet aggregation and thromboxane A2 generation mediated by Gi signalling pathways. Biochem J 2010, 429:369-377.
76. Guidetti G.F., Lova P., Bernardi B., Campus F., Baldanzi G., Graziani A., et al. The Gi-coupled P2Y12 receptor regulates diacylglycerol-mediated signaling in human platelets. J Biol Chem 2008, 283:28795-28805.
77. Woulfe D. Activation of Rap1B by Gi family members in platelets. J Biol Chem 2002, 277:23382-23390.
78. Picker S.M., Speer R., Gathof B.S. Functional characteristics of buffy-coat PLTs photochemically treated with amotosalen-HCl for pathogen inactivation. Transfusion 2004, 44:320-329.
79. van Rhenen D.J., Vermeij J., Mayaudon V., Hind C., Lin L., Corash L. Functional characteristics of S-59 photochemically treated platelet concentrates derived from buffy coats. Vox Sang 2000, 79:206-214.
80. Apelseth T.Ø., Bruserud Ø., Wentzel-Larsen T., Bakken A.M., Bjørsvik S., Hervig T. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage. Transfusion 2007, 47:653-665.
81. Chavarin P., Cognasse F., Argaud C., Vidal M., De Putter C., Boussoulade F., et al. In vitro assessment of apheresis and pooled buffy coat platelet components suspended in plasma and SSP+ photochemically treated with amotosalen and UVA for pathogen inactivation (INTERCEPT Blood System™). Vox Sang 2011, 100:247-249.
82. Picker S.M., Oustianskaia L., Schneider V., Gathof B.S. Annexin V release and transmembrane mitochondrial potential during storage of apheresis-derived platelets treated for pathogen reduction. Transfus Med Hemother 2010, 37:7-12.
83. Picker S.M., Oustianskaia L., Schneider V., Gathof B.S. Functional characteristics of apheresis-derived platelets treated with ultraviolet light combined with either amotosalen-HCl (S-59) or riboflavin (vitamin B2) for pathogen-reduction. Vox Sang 2009, 97:26-33.
84. Malik M., Shukla A., Amin P., Niedelman W., Lee J., Jividen K., et al. S-nitrosylation regulates nuclear translocation of chloride intracellular channel protein CLIC4. J Biol Chem 2010, 285:23818-23828.
85. Palmfeldt J., Vang S., Stenbroen V., Pavlou E., Baycheva M., Buchal G., et al. Proteomics reveals that redox regulation is disrupted in patients with ethylmalonic encephalopathy. J Proteome Res 2011, 10:2389-2396.
86. Singh H., Cousin M.A., Ashley R.H. Functional reconstitution of mammalian "chloride intracellular channels" CLIC1, CLIC4 and CLIC5 reveals differential regulation by cytoskeletal actin. FEBS J 2007, 274:6306-6316.
87. Shiio Y., Suh K.S., Lee H., Yuspa S.H., Eisenman R.N., Aebersold R. Quantitative proteomic analysis of myc-induced apoptosis: a direct role for Myc induction of the mitochondrial chloride ion channel, mtCLIC/CLIC4. J Biol Chem 2006, 281:2750-2756.
88. Reid S., Johnson L., Woodland N., Marks D.C. Pathogen reduction treatment of buffy coat platelet concentrates in additive solution induces proapoptotic signaling. Transfusion 2012, http://dx.doi.org/10.1111/j.1537-2995.2011.03558.
89. Carvalho H., Alguero C., Santos M., de Sousa G., Trindade H., Seghatchian J. The combined effect of platelet storage media and intercept pathogen reduction technology on platelet activation/activability and cellular apoptosis/necrosis: Lisbon-RBS experience. Transfus Apher Sci 2006, 34:187-192.
90. Dasgupta S.K., Argaiz E.R., Mercado J.E.C., Maul H.O.E., Garza J., Enriquez A.B., et al. Platelet senescence and phosphatidylserine exposure. Transfusion 2010, 50:2167-2175.
91. Schubert P., Devine D.V. De novo protein synthesis in mature platelets: a consideration for transfusion medicine. Vox Sang 2010, 99:112-122.
92. Estebanell E., Diaz-Ricart M., Lozano M., Mazzara R., Escolar G., Ordinas A. Cytoskeletal reorganization after preparation of platelet concentrates, using the buffy coat method, and during their storage. Haematologica 1998, 83:112-117.